Evidence map›Paper›PMID 39863877›Full record

ArticleBMC bioinformatics2025

HDN-DDI: a novel framework for predicting drug-drug interactions using hierarchical molecular graphs and enhanced dual-view representation learning.

Jinchen Sun, Haoran Zheng

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jinchen SunSchool of Computer Science and Technology, University of Science and Technology of China, 443 Huangshan Road, Hefei, 230027, China.
Haoran ZhengSchool of Computer Science and Technology, University of Science and Technology of China, 443 Huangshan Road, Hefei, 230027, China. hrzheng@ustc.edu.cn.

Funding

National Key Technologies R&D Program of China 2017YFA0505502Strategic Priority Research Program of the Chinese Academy of Sciences XDB38000000
6 · The paper itself

Abstract

backgroundDrug-drug interactions (DDIs) especially antagonistic ones present significant risks to patient safety, underscoring the urgent need for reliable prediction methods. Recently, substructure-based DDI prediction has garnered much attention due to the dominant influence of functional groups and substructures on drug properties. However, existing approaches face challenges regarding the insufficient interpretability of identified substructures and the isolation of chemical substructures.

resultsThis study introduces a novel framework for DDI prediction termed HDN-DDI. HDN-DDI integrates an explainable substructure extraction module to decompose drug molecules and represents them using innovative hierarchical molecular graphs, which effectively incorporates information from real chemical substructures and improves molecules encoding efficiency. Furthermore, the enhanced dual-view learning method inspired by the underlying mechanisms of DDIs enables HDN-DDI to comprehensively capture both hierarchical structure and interaction information. Experimental results demonstrate that HDN-DDI has achieved state-of-the-art performance with accuracies of 97.90% and 99.38% on the two widely-used datasets in the warm-start setting. Moreover, HDN-DDI exhibits substantial improvements in the cold-start setting with boosts of 4.96% in accuracy and 7.08% in F1 score on previously unseen drugs. Real-world applications further highlight HDN-DDI's robust generalization capabilities towards newly approved drugs.

conclusionWith its accurate predictions and robust generalization across different settings, HDN-DDI shows promise for enhancing drug safety and efficacy. Future research will focus on refining decomposition rules as well as integrating external knowledge while preserving the model's generalization capabilities.

Indexed as

Computational BiologyMachine LearningAlgorithmsDrug InteractionsHumansChemical substructuresDrug-drug interactionsDual-view representation learningGraph attention networkHierarchical molecular graphs

Identifiers

PMID39863877
PMCPMC11765940

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.